Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

Financial Times

BusinessFinancial Times·Aug 4, 2026·1 min read

‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker

Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs

View original source — Financial Times ↗

ShareShare on X Share on Facebook

Related stories

Could heatwaves make your food shop more expensive?

BusinessAug 4, 2026 · 1 min

Could heatwaves make your food shop more expensive?

BusinessAug 4, 2026 · 1 min

HSBC's Elhedery on Buybacks and Vision for Bank Overhaul

BusinessAug 4, 2026 · 1 min

Zimbabwe: Supreme Court Throws Out Ex-NSSA Boss Vela's Appeal Bid in Debt Dispute

Saudi Aramco profits soar in second quarter as Iran war squeezes oil supply

BusinessAug 4, 2026 · 1 min

Saudi Aramco profits soar in second quarter as Iran war squeezes oil supply